Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 39.02% vs -54.47% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -32.71% vs -18.97% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is -5.14% vs -13.95% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 4.65% vs -13.47% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of Hansa Biopharma AB With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 39.02% vs -54.47% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -2.04% vs 43.15% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is -32.71% vs -18.97% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -45.61% vs 13.95% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is -5.14% vs -13.95% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 3.92% vs 14.42% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 4.65% vs -13.47% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 339.85% vs -49.81% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025






